CALCULATE YOUR SIP RETURNS

Welcure Drugs & Pharmaceuticals Ltd Share Price Live

0.57

+0.02(3.64%)

Live Welcure Drugs & Pharmaceuticals Share Price Chart

Welcure Drugs & Pharmaceuticals Performance

Days Range

Previous Close₹0.55
Open₹0.57
Volume1,44,49,711
Day's Range₹0.55 - ₹0.57
52W Range₹0.48 - ₹1.44
Market Cap₹67.98 Cr

Welcure Drugs & Pharmaceuticals Fundamentals

ROCE(TTM)17.53
P/E Ratio (TTM)1.96
P/B Ratio0.51
Industry P/E40.36
Debt to Equity0.92
ROE25.60
EPS (TTM)0.28
Dividend Yield0
Book Value1.09
Face Value1
ROCE(TTM)17.53
P/E Ratio (TTM)1.96
P/B Ratio0.51
Industry P/E40.36
Debt to Equity0.92
ROE25.60
EPS (TTM)0.28
Dividend Yield0
Book Value1.09
Face Value1

Welcure Drugs & Pharmaceuticals Financials

Dec 2024Mar 2025Jun 2025Sep 2025
Net Sales0.8821.21299.9165.62
Expenses0.7920.58268.7854.26
Profit before tax0.092.5431.1411.36
Operating Profit0.042.5423.308.50
Net Profit0.042.5423.308.50
ESP in Rs0.040.332.070.76

Welcure Drugs & Pharmaceuticals Shareholding Pattern

Held bySep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters0%0%0%0%0%
Flls0%0%0%0%0%
Dlls0%0%0%0%0%
Public100%100%100%100%100%

About Welcure Drugs & Pharmaceuticals

Incorporated on 4 Jun.'92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. The company is managed by managing director D C Jain. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market. The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for a unique medicine Stevioside, an alternate to sugar, Saccharin and Aspartame. The Company has added a new liquid oral plant in Bhiwadi, Rajasthan. It has obtained ISO 9002 certification with double accredition from ABS Quality Evaluation Inc Texas and by Registrar of Accredition Board of USA. Welcure has also entered into an agreement with Bihar Drugs and Chemicals Ltd, a government of Bihar undertaking, for manufacturing their products in its factory on loan basis. During the year 2000-01 the company had launched some products like CEZEN,DIMCIN PLUS,OXIN,SPASWIN etc.The company has entered into technical collaboration agreement with Advanced Medical Care Inc New Jersey USA for setting up of joint venture facilities in the existing plant of the company. During the year 2001-02, the company had launched products like B-ZEX, DMART PLUS, DRALPIN, DUKESPAS, DUBAMOL, HISTACURE, KUFFWEL, KINGSPAS, LANAX, PETRIMAX, PEEROSCAM, RENACT, SARVO, WELCEE, WELGESIC, WELIC, WELOXY, WELRELEEF, X-DRYL. The company has changed its marketing policy from "Sales through Wholesale Distributors" to " Sales at Doorstep" by reaching every corner of the country and by putting dual force on Sales-through sales personnel on one hand and through stockists and distributors on the other hand.

Parent Organisation
Indian Private
Managing Director
None
Founded
1996
NSE Symbol

Welcure Drugs Pharmaceuticals Share Price History

Welcure Drugs Pharmaceuticals Share Price History

ParticularsDetails
5-Year % change in Welcure Drugs Pharmaceuticals share price1926.09%
5-Year Highest in Welcure Drugs Pharmaceuticals share price₹ 15.81
5-Year Lowest in Welcure Drugs Pharmaceuticals share price₹ 0.42
1-Year % change in Welcure Drugs Pharmaceuticals share price96.62%
1-Year Highest in Welcure Drugs Pharmaceuticals share price₹ 15.81
1-Year Lowest in Welcure Drugs Pharmaceuticals share price₹ 4.3

Top Mutual Funds Invested in Welcure Drugs Pharmaceuticals Share

Top Mutual Funds Invested in Welcure Drugs Pharmaceuticals Share

FUND NAMEAUM(%)

Peer Comparison

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,799.9
-7.50 (-0.41%)
₹4,33,763.771,548.0 - 1,910.0View Stocks
Divis Laboratories Ltd6,410.5
-12.00 (-0.19%)
₹1,70,489.234,955.0 - 7,071.5View Stocks
Torrent Pharmaceuticals Ltd3,726.9
-10.00 (-0.27%)
₹1,26,435.852,886.45 - 3,882.2View Stocks
Cipla Ltd1,514.8
-8.30 (-0.54%)
₹1,23,088.181,335.0 - 1,673.0View Stocks
Dr Reddys Laboratories Ltd1,273.8
13.70 (1.09%)
₹1,05,162.271,020.0 - 1,405.9View Stocks
Lupin Ltd2,080.2
-1.70 (-0.08%)
₹95,296.581,795.2 - 2,402.9View Stocks

Welcure Drugs Pharmaceuticals Ltd FAQs

Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) share price as of December 2, 2025, on NSE is Rs 0.57 (NSE) and Rs 0.57 (BSE) on BSE.
Yes, You can buy Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Welcure Drugs Pharmaceuticals Ltd (Welcure Drugs Pharmaceuticals Ltd) shares.
Open Free Demat Account!
Join our 3 Cr+ happy customers